General overviews

Eisenberg, D.M., Kessler, R.C., Foster, C. et al (1993). Unconventional medicine in the United States. Prevalence, costs and pattern of use. N Engl J Med, 328, 246-252.

Ernst, E., Schmidt, K. (2004) Alternative' cures for depression--how safe are web sites? Psychiatry Res, 129, 297-301.

Freeman, M.P., Hibblen, J.R., Wisner, K.L., et al (2006). Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry.Jounral of Clinical Psychiatry, 67, 1954-1967.

Fugh-Berman, A. (2000) Herb-drug interactions. Lancet, 355,134-138.

Heck, A.M., DeWitt, B.A. & Lukes, A.L. (2000). Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm,  57, 1221-1227.

Klepser, T.B. &  Klepser, M.E. (1999). Unsafe and potentially safe herbal therapies. Am J Health Syst Pharm, 56, 125-138.

Miller, L.G. (1989). Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med, 158, 2200-2211.

Werneke, U. Complementary Medicine in Psychiatry, Evidence Based Mental Health, 12, 1-4, 2009.

Werneke, U., Turner, T. & Priebe, S. (2006). Complementary alternative medicine in psychiatry: a review of effectiveness and safety. British Jounral of Psychiatry, 188, 109-121.

Werneke, U., Ladenheim, D., McCarthy, T. (2004). Complementary alternative medicine for cancer: a review of effectiveness and safety. Cancer-Therapy,  475-500.

Improving brain function and dementia

Birks, J. & Grimley Evans, J. Gingko Biloba for Cognitive Impairment and Dementia. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD003120. DOI: 10.1002/14651858. CD003120. Pub3.

Bjelakovic, G., Nikolovba, D., Gluud L.L., Sominetti, R.G., Gluud, C. (2007) Mortality in Randomized Trials od Antioxidant Supplements for Primary and Secondary Prevention: Systematic Review and Meta-Analysis, JAMA, 297, 842-857.

McDonald, R.J. (1979) Hydergine: a review of 26 clinical studies. Pharmakopsychiatr Neuropsychopharmakol, 12, 407-22.

Olin, J., Schneider, L., Novit, A. et al (2003) Hydergine for dementia (Cochrane Review). In: The Cochrane Library, Issue 4, 2003. Chichester, UK: John Wiley & Sons, Ltd.

Tabet, N., Birks, J., Grimley Evans, J.  (2004) Vitamin E for Alzheimer's disease. In: The Cochrane Library, Issue 1, Chichester, UK: John Wiley & Sons, Ltd.

Vogeler, B.K., Pittler, M.H., Ernst, E. (1999) The efficacy of ginseng. A systematic review of randomized controlled trials. European Jounral of Clinical Pharmacology, 55, 567-575.

No author listed (2008). Haemorrhage due to Gingki Biloba. Prescrire Int, 93,19.

Anxiety and sleep problems

Bent, S. Padula, A., Patterson, M.,

Mehling, W. (2006) Valerian for Sleep: A systematic review and meta-analysis, Am J Med, 119, 1005-1012.

Diaper, A., Hindmarch, I. (2004). A double-blind, placebo-controlled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor function of sleep-disturbed older adults. Phytother Res, 18, 831-836.

Dorn, M. (2000). Efficacy and tolerabilityof Baldrian versus Oxazepam in non-organic and non-psychiatric insomniacs: a randomized, double blind, clinical comparative study. Forsch Komplementarmed Klass Naturheilk, 7, 79-84.

Ernst, E. (2006). Herbal remedies for anxiety - a systematic review of controlled clinical trials.Phytomedicine, 13, 205-208.

Ernst, E. (2002). "Flower remedies": a systematic review of the clinical evidence. Wien Klin Wochenschr, 30, 963-966.

Herxheimer, A. & Petrie, K.J. (2003). Melatonin for the prevention and treatment of jet lag (Cochrane Review). In: The Cochrane Library, Issue 4, Chichester, UK: John Wiley & Sons, Ltd

MacMahon, K.M.A., Broomfield, N.M., Espie, C.A. (2005). A systematic review of the effectiveness of oral melatonin for adults (18 to 65 years) with delayed sleep phase syndrome and adults (18 to 65 years) with primary insomnia. Current Psych Rev, 1, 103-113.

Stevinson, C. & Ernst, E. (2000). Valerian for insomnia: a systematic review of randomized clinical trials. Sleep Medicine, 1, 91-99.

Taibi, D.M., Landis, C.A., Petry, H. & Vitiello, M.V. (2007) A systematic review of Valerian as a Sleep Aid: Safe but not Effective. Sleep Med. Rev., 11, 209-320.

Ziegler, G., Ploch, M., Miettinen-Baumann, A. (2002). Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia--a randomized, double-blind, comparative clinical study. Eur J Med Res, 25, 480-486.

Depression and bipolar affective disorder

Bressa, G.M. (1994). S-adenosyl-l-methionine (SAME) as antidepressant: meta-analysis of clinical studies. Acta Neurol Scand, 154, (Suppl.), 7-14.

Committee of Safety in Medicine & Medicines Control Agency (2000). Reminder: St John’s wort (Hypericum perforatum) interactions. Current problems in pharmacovigilance, 26, 6-7.

Freeman, M.P., Hibbeln, J.R., Wisner, K.L., Davis, J.M., Mischoulon, D.. Peet, M. et al (2006) Omega-3 Fatty Acids: Evidence basis for treatment and future research in psychiatry. J.Clin. Psychiatry, 67, 1954-1967.

Knuppel, L., Linde, K. (2004). Adverse effects of St. John's Wort: a systematic review. Journal of Clinical Psychiatry,65,1470-1479.

Linde, K., Berner, M., Egger, M. et al (2005). St John's wort for depression: Meta-analysis of randomised controlled trials. British Journal of Psychiatry, 186, 99-107.

Linde, K., Ramirez, G., Mulrow, C.D. et al (1996). St John’s wort for depression-an overview and meta-analysis of the randomised clinical trials. British Medical Journal, 313, 253-258.

Montgomery, P. & Richardson, A.J. (2008) Omega-3 Fatty Acids for Bipolar Disorder. Cochrane Database of Systematic Reviews 2008, Issue 2. Art.No. CD005169. DOI:10.1002/14651858.CD005169.PUB 2.

Szegedi, A., Kohnen, R. Dienel, a. et al (2005). Acute treatment of moderate to severe depression with hypericum extract WS5570 (St John’s wort): randomised controlled double blind non-inferiority trial against paroxetine. Brisitsh Medical Journal, 330, 503-506.

Taylor, M.J., Carney, S., Geddes, J. et al (2004). Folate for depressive disorders.
(Cochrane Review). In: The Cochrane Library, Issue 1, Chichester, UK: John Wiley & Sons, Ltd.

Thachil, A.F., Mohan, R., Bugra, D. (2007). The evidence base of complementary and alternative therapies in depression.Journal of Affective Disorders, 97, 23-35. 

Werneke, U., Horn, O., Taylor, D. (2004b). How effective is St John’s wort? – The evidence revisited. Journal of Clinical Psychology, 65, 611-617.

Whiskey, E., Werneke, U., Taylor, D. (2001). A systematic review of hypericum perforatum in depression. International Clinical Psychopharmacology, 16, 239-252.

Psychotic states

Joy, C.B., Mumby-Croft, R., Joy, L.A. (2003). Polyunsaturated fatty acid supplementation for schizophrenia (Cochrane Review). In: The Cochrane Library, Issue 4, Chichester, UK: John Wiley & Sons, Ltd.

Movement disorders

Shamir, E., Barak, Y., Shalman, I. (2001). Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study. Arch Gen Psychiatry, 58, 1049-1052.

Shamir, E., Barak, Y., Plopsky, I. et al (2000). Is melatonin treatment effective for tardive dyskinesia? Journal of Clinical Psychiatry, 61, 556-8.

Soares, K.V.S. & McGrath, J.J. (2003). Vitamin E for neuroleptic-induced tardive dyskinesia (Cochrane Review). In: The Cochrane Library, Issue 4, Chichester, UK: John Wiley & Sons, Ltd.

Addiction

Overstreet, D.H., Keung, W.M., Rezvani, A.H. et al (2003). Herbal remedies for alcoholism: promises and possible pitfalls. Alcohol Clin Exp Res, 27, 177-185.

My Eboga 2007. myeboga.com/fatalities.html

Vastag, B. (2005). Addiction research. Ibogaine therapy: a 'vast, uncontrolled experiment'. Science, 308, 345-346.